UNSPSC 51282947: Tioxacin

This classification denotes a quinolone antibiotic with the molecular formula C14H12N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0K40CNM74K, chemically known as 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo(5,4-f)quinoline-8-carboxylic acid but generally known as tioxacin, which bears US NIH Compound Identifier 65788. European Medicines Agency schedules Tioxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11096MIG.

UNSPSC 51282947 Tioxacin is a Commodity code under which state and local governments procure pharmaceutical products and medical supplies, though recent solicitations tagged to this code show a mismatch between the nominal category name and actual buying activity. The opportunities posted under this code reflect purchasing of naloxone and drug deactivation systems, generic pharmaceuticals and over-the-counter products, and emergency medical supplies for fire rescue operations—a mix that spans public health agencies, healthcare systems, and first-responder organizations rather than tioxacin (an antibacterial agent) specifically. State and local issuing bodies soliciting under this code include county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances spanning multiple states. The buying activity ranges from direct procurement of specific medical products through competitive sealed bidding to participation in multi-state cooperative purchasing frameworks that aggregate demand across participating jurisdictions.

Recent opportunities show activity concentrated in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, response due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program serving state pharmacy benefit functions. The City of Tampa's Purchasing Department solicited sealed bids (26P00145) in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 in January 2026 to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code shows little activity directly aligned with tioxacin procurement; vendors pursuing opportunities under this code should verify the actual product or service scope in individual RFP and IFB documents rather than relying on the category name.